Bindazyme Clq Cic Eia Kit
by The Binding Site, Ltd. 510(k)
Active
510(k) K031563
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK031563 | Date10 Sep 2003 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Terminated Z-1942-2010
The recall was initiated after the binding site notified Inova Diagnostics, inc. that the affected Bindazyme Human C1q binding Circulating Immune Complex EIA Kits may contain an ELISA plate labeled as "tissue Transglutaminase Coated Wells" instead of "C1q Coated Wells".
Specification
- 510(k) Number
- FDA Product Code
- DAK
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5240
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent